Before Invest
AbbVie Inc. logo

AbbVie Inc.

ABBV
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 10 years
Format
% Change
Rows
USD ($)
$ in Millions 		Dec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013
Current assets
             
Cash and equivalents
$ 5,229
$ 5,524
$ 12,814
Short-term investments
28
31
2
Accounts receivable, net
12,589
10,919
11,155
Inventories
4,951
4,181
4,099
Income tax receivable
-
-
-
Deferred income taxes
-
-
-
Prepaid expenses and other
6,265
4,927
4,932
Total current assets
29,062
25,582
33,002
Investments
268
279
304
Property and equipment, net
5,628
5,134
4,989
Intangible assets, net
52,641
60,068
55,610
Goodwill
35,640
34,956
32,293
Other assets
10,721
9,142
8,513
Total assets
133,960
135,161
134,711
Liabilities and Equity
             
Current liabilities
             
Short-term borrowings
2,499
-
0
Current portion of long-term debt and finance lease obligations
6,056
6,804
7,191
Accounts payable and accrued liabilities
34,734
31,945
30,650
Total current liabilities
43,289
38,749
37,841
Long-term debt and finance lease obligations
58,941
60,340
52,194
Deferred income taxes
2,389
2,579
1,952
Other long-term liabilities
32,569
30,129
32,327
Stockholders' equity (deficit)
             
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,838,678,628 shares issued as of December 31, 2025 and 1,831,594,494 as of December 31, 2024
18
18
18
Common stock held in treasury, at cost, 70,802,593 shares as of December 31, 2025 and 66,337,508 as of December 31, 2024
9,146
8,201
6,533
Additional paid-in capital
22,495
21,333
20,180
Accumulated deficit
(15,493)
(7,900)
(1,000)
Accumulated other comprehensive loss
(1,144)
(1,925)
(2,305)
Total stockholders' equity (deficit)
(3,270)
3,325
10,360
Noncontrolling interest
42
39
37
Total equity (deficit)
(3,228)
3,364
10,397
Total liabilities and equity
$ 133,960
$ 135,161
$ 134,711